At Simulation World Detroit, executives shared their views on the early integration of AI, data, models, and simulations to ...

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026 New preclinical data demonstrated SIL204’s exceptional efficacy across multiple human cancer cell ...